Patents by Inventor R. Andrew Cuthbertson

R. Andrew Cuthbertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biologically active substance-secreting hybrid gel
    Patent number: 6485721
    Abstract: The present invention provides a biologically active substance secreting hybrid gel, which consists essentially of a biopolymeric gel and cells containing an expression vector with a gene encoding the biologically active substance to produce the substance. According to the present invention, it is possible to develop a gene therapy by skin transplantation allowing stable drug medication for a long time; alleviating pains of patients; and allowing fine adjustment of the dosage and control of genes externally without using retrovirusderived vector that tend to invoke the risk of mutation to wild types as in the conventional prescription.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: November 26, 2002
    Assignees: Research Development Corporation of Japan, Genentech, Inc.
    Inventors: Susumu Yoshida, R. Andrew Cuthbertson, Katsutoshi Yoshizato
  • Ocular gene therapy
    Patent number: 6204251
    Abstract: The invention relates to methods of ocular gene therapy.
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: March 20, 2001
    Assignee: Genentech, Inc.
    Inventor: R. Andrew Cuthbertson
  • Ocular gene therapy
    Patent number: 5827702
    Abstract: The invention relates to methods of ocular gene therapy.
    Type: Grant
    Filed: October 31, 1994
    Date of Patent: October 27, 1998
    Assignee: Genentech, Inc.
    Inventor: R. Andrew Cuthbertson